Packing slower
1H23 RESULTS
Need To Know
- Result in-line with consensus, sales up 2% to $7,354m, EBIT up 8% to $791m (constant currency)
- Quarterly dividend increased to 12.25cps (from 12.0), additional $100m of buybacks announced
- FY23 guidance maintained ($1.0-$1.1b free cash flow, $0.77-$0.81 eps)
Amcor (AMC) packaged its results in-line with consensus at an EBIT level, with constant currency sales growth of 2% reflecting a price/mix benefit of ~3%, partly offset by ~1% lower volumes. AMC maintained its FY23 guidance, although is likely tracking closer to the lower end given softer volumes, unfavourable FX and higher working capital.
Flexibles. Sales were 3% higher driven by price/mix benefits, partly offset by lower volumes. Healthcare, cheese, pet care and home and personal categories all saw volume growth, offset by lower volumes in condiments, fresh meat, snacks and confectionary. EBIT rose 8% reflecting strong operating cost performance, however the margin was impacted by higher raw materials.
Rigids. Constant currency sales fell -1%, reflecting lower volumes driven by falling demand and customer destocking, partly offset by new business wins. Year to date, speciality container volumes were higher driven by growth in healthcare, dairy and nutrition end markets.
Weaker cash flow. Free cash flow for the half was negative -$61m, predominantly impacted by working capital from higher inventory levels and higher raw material costs. The December quarter saw cash inflow of $338m, in line with the same quarter in the previous year. For AMC to reach the midpoint of its guidance, it would need to generate >10% more FCF in 2H23.
Capital management. AMC raised its dividend to 12.25cps, up from 12.0cps. AMC also increased its buyback program by $100m to a total of $500m. Net debt was $6,065m, with leverage at 2.8x trailing EBITDA, comfortably within its long-term averages.
Russian divestment. The Russian business was divested in December, receiving $365m in addition to approximately $65m of cash on hand which was repatriated upon close. Approximately $120m of the cash is expected to be invested in a range of cost saving initiatives with the remainder expected to fund the buyback and reduce debt. The sale is expected to negatively impact FY23 eps by ~3%.
Investment View
Whilst the result was in line, AMC will need a significant 2H to reach the midpoint of its FY23 guidance on a free cash flow basis. We however expect some of the raw materials price increases to unwind as supply chains ease, improving margins. AMC is more cautious about the demand outlook and is increasingly likely to report the lower end of its guided range. We retain our Hold recommendation.
Figure 1: Higher Russia impact partly offset by lower expected fx impact
Stock Overview
Share Price
Company Overview
Amcor is a global producer of packaging for food, beverage, pharmaceutical, medical, home, and personal care products. The company supplied flexible and rigid packaging, specialty cartons, closures, and services. AMC products are increasingly light-weight, reusable and recyclable.
Disclaimers and Disclosures
Issuer
The information and opinions contained within Sandstone Insights Research were prepared by MST Financial Services Pty Ltd (ABN 54 617 475 180, AFSL 500557) ("MST").
Reliance
Whilst MST make every effort to use reliable, comprehensive information in the construction of its reports, MST make no representation, warranty or undertaking of the accuracy, timeliness or completeness of information in this report. Save for any statutory liability that cannot be excluded, MST and MST employees, representative and agents shall not be liable (whether in negligence or otherwise) for any error or inaccuracy in, or omission from, this advice or any resulting loss suffered by the recipient or any other person.
General Advice
Any advice contained within Sandstone Insights Research is general advice only and has been prepared without taking into account any person’s objectives, financial situation or needs. Any person, before acting on any advice contained within Sandstone Insights Research, should first consider consulting with a financial adviser to assess whether that advice is appropriate for their objectives, financial situation and needs.
General Disclosures
This report should be read in conjunction with MST Disclaimers and Disclosures and is published in accordance with MST Conflict Management Policy which are available on the MST website: https://www.sandstoneinsights.com.au.
Currency of Research
The recommendations made in a Sandstone Insights Research report are current as of the publication date. If you are reading a report materially after publication, it is likely that circumstances will have changed and at least some aspects of the analysis may no longer hold.
Access and Use
Any access to or use of Sandstone Insights Research is subject to the Terms of Use. By accessing or using Sandstone Insights Research you hereby agree to be bound by our Terms and Conditions and hereby liable for any monies due in payment of accessing this service. In addition you consent to us collecting and using your personal data (including cookies) in accordance with MST Privacy Policy, including for the purpose of a) setting your preferences and b) collecting readership data so MST may deliver an improved and personalised service to you. If you do not agree to MST Terms of Use and/or if you do not wish to consent to MST use of your personal data, please do not access this service.
Equities Research Methodology
Please click here for information about MST equities research methodology.